Sheehan's syndrome overview: Difference between revisions
Iqra Qamar (talk | contribs) No edit summary |
Iqra Qamar (talk | contribs) |
||
| Line 20: | Line 20: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
The | The incidence of Sheehan's syndrome is difficult to assess.<ref name="pmid303183">{{cite journal |vauthors=Asaoka K |title=[A study on the incidence of post-partum hypopituitarism, (Sheehan's syndrome)] |language=Japanese |journal=Nihon Naibunpi Gakkai Zasshi |volume=53 |issue=7 |pages=895–909 |year=1977 |pmid=303183 |doi= |url=}}</ref> It was found to be the 6th most common cause of GH deficiency with an incidence of 3.1% of cases.<ref name="pmid10468941">{{cite journal |vauthors=Abs R, Bengtsson BA, Hernberg-Stâhl E, Monson JP, Tauber JP, Wilton P, Wüster C |title=GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety |journal=Clin. Endocrinol. (Oxf) |volume=50 |issue=6 |pages=703–13 |year=1999 |pmid=10468941 |doi= |url=}}</ref> In 2009, the prevalence of Sheehan's syndrome was estimated to be 5.1 per 100,000 women.It is less prevalent in developed countries due to better obstetrical care and maternal health awraeness.<ref name="pmid16213852">{{cite journal |vauthors=Feinberg EC, Molitch ME, Endres LK, Peaceman AM |title=The incidence of Sheehan's syndrome after obstetric hemorrhage |journal=Fertil. Steril. |volume=84 |issue=4 |pages=975–9 |year=2005 |pmid=16213852 |doi=10.1016/j.fertnstert.2005.04.034 |url=}}</ref><ref name="pmid26817341">{{cite journal |vauthors=Krysiak R, Okopień B |title=[Sheehan's syndrome--a forgotten disease with 100 years' history] |language=Polish |journal=Prz. Lek. |volume=72 |issue=6 |pages=313–20 |year=2015 |pmid=26817341 |doi= |url=}}</ref> It is still one of the most common causes of hypopituitarism in developing countries.<ref name="pmid26817341">{{cite journal |vauthors=Krysiak R, Okopień B |title=[Sheehan's syndrome--a forgotten disease with 100 years' history] |language=Polish |journal=Prz. Lek. |volume=72 |issue=6 |pages=313–20 |year=2015 |pmid=26817341 |doi= |url=}}</ref> | ||
==Risk Factors== | ==Risk Factors== | ||
Common | Common risk factors in the development of Sheehan's syndrome include pregnancy, severe/massive PPH, pituitary mass, pre-existing vascular diseases, autoimmunity,type 1 Diabetes, DIC, smaller and rigid sella, multiple gestations, placental abnormalities and traumatic delivery. | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine | There is insufficient evidence to recommend routine screening for Sheehan's syndrome. | ||
==Natural History, Complications, and Prognosis== | ==Natural History, Complications, and Prognosis== | ||
Sheehan's syndrome, if left untreated lead to | Sheehan's syndrome, if left untreated lead to hypopituitarism and empty sella syndrome. Common complications include adrenal crisis, hypotension, hypothyroidism and hypopituitarism. Prognosis is generally excellent provided early diagnosis and management resulting in complete reversal of symptoms. | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis is made on | Diagnosis is made on clinical basis with a recent/remote history of traumatic delivery or delivery complicated by hypotension. Diagnosis is mostly clinical but detailed medical history, measurement of pituitary hormone levels in blood, pituitary hormone stimulation tests and imaging (MRI preferred on CT) studies can help in making the diagnosis. | ||
===History and Symptoms=== | ===History and Symptoms=== | ||
The most common symptoms of Sheehan's sydrome include agalactorrhea and failure to resume | The most common symptoms of Sheehan's sydrome include agalactorrhea and failure to resume menstruation after parturition. Common symptoms include hot flushes, decreased pubic/axillary hair, hypotension, hypoglycemia, features of hypothyroidism, hypoadrenalism and hypogonadism. | ||
===Physical Examination=== | ===Physical Examination=== | ||
Patients with syndrome usually appear | Patients with syndrome usually appear fatigued, lethargic and weight gain. Physical examination is usually remarkable for bradycardia, hypotension, pallor and signs suggestive of respective hormonal deficiency. | ||
===Laboratory Findings=== | ===Laboratory Findings=== | ||
Laboratory findings consistent with the diagnosis of Sheehan's syndrome include | Laboratory findings consistent with the diagnosis of Sheehan's syndrome include hyponatremia, hypokalemia, hypocalcemia, hypomagnesemia, hypophosphatemia, anemia, pancytopenia, eosinophilia, hypoalbuminemia, low fasting plasma glucose etc. | ||
===Electrocardiogram=== | ===Electrocardiogram=== | ||
ECG findings associated with Sheehan's syndrome can include QT interval prolongation,Type-1 Brugada-like ECG pattern(due to adrenal crisis),findings suggestive of cardiac tamponade, dilated cardiomyopathy(multifactorial).<ref name="pmid25771803">{{cite journal |vauthors=Komuro J, Kaneko M, Ueda K, Nitta S, Kasao M, Shirai T |title=Adrenal insufficiency causes life-threatening arrhythmia with prolongation of QT interval |journal=Heart Vessels |volume=31 |issue=6 |pages=1003–5 |year=2016 |pmid=25771803 |pmc=4893060 |doi=10.1007/s00380-015-0660-6 |url=}}</ref><ref name="pmid24718975">{{cite journal |vauthors=Anselm DD, Baranchuk A |title=Confirmed Brugada phenocopy in the setting of hypopituitarism |journal=Herz |volume=40 |issue=4 |pages=639–40 |year=2015 |pmid=24718975 |doi=10.1007/s00059-014-4075-4 |url=}}</ref><ref name="pmid28365624">{{cite journal |vauthors=Martin-Grace J, Ahmed M, Mulvihill N, Feeney ER, Crowley RK |title=Getting to the heart of hypopituitarism |journal=Clin Med (Lond) |volume=17 |issue=2 |pages=140–142 |year=2017 |pmid=28365624 |doi=10.7861/clinmedicine.17-2-140 |url=}}</ref><ref name="pmid23513050">{{cite journal |vauthors=Doshi S, Roy A, Ramamoorthy A, Kothari SS, Bahl VK |title=Dilated cardiomyopathy: a ghost from the past |journal=Circ Heart Fail |volume=6 |issue=2 |pages=e19–21 |year=2013 |pmid=23513050 |doi=10.1161/CIRCHEARTFAILURE.112.000062 |url=}}</ref> | |||
===X-ray=== | ===X-ray=== | ||
There are no | There are no x-ray findings associated with Sheehan's syndrome. | ||
===CT scan=== | ===CT scan=== | ||
Acute presentation shows non- | Acute presentation shows non-hemorrhagic pituitary gland enlargement while chronic presentation shows an empty sella or decreased sellar volume.<ref name="pmid2750772">{{cite journal |vauthors=Barkan AL |title=Pituitary atrophy in patients with Sheehan's syndrome |journal=Am. J. Med. Sci. |volume=298 |issue=1 |pages=38–40 |year=1989 |pmid=2750772 |doi= |url=}}</ref><ref name="pmid2591059">{{cite journal |vauthors=Sherif IH, Vanderley CM, Beshyah S, Bosairi S |title=Sella size and contents in Sheehan's syndrome |journal=Clin. Endocrinol. (Oxf) |volume=30 |issue=6 |pages=613–8 |year=1989 |pmid=2591059 |doi= |url=}}</ref><ref name="pmid1906495">{{cite journal |vauthors=Bakiri F, Bendib SE, Maoui R, Bendib A, Benmiloud M |title=The sella turcica in Sheehan's syndrome: computerized tomographic study in 54 patients |journal=J. Endocrinol. Invest. |volume=14 |issue=3 |pages=193–6 |year=1991 |pmid=1906495 |doi=10.1007/BF03346787 |url=}}</ref> | ||
===MRI=== | ===MRI=== | ||
Findings on | Findings on MRI suggestive of Sheehan's syndrome include decreased sellar volume, empty sella, pituitary remnant tissue or CSF fluid in sella.<ref name="pmid2750772">{{cite journal |vauthors=Barkan AL |title=Pituitary atrophy in patients with Sheehan's syndrome |journal=Am. J. Med. Sci. |volume=298 |issue=1 |pages=38–40 |year=1989 |pmid=2750772 |doi= |url=}}</ref><ref name="pmid2591059">{{cite journal |vauthors=Sherif IH, Vanderley CM, Beshyah S, Bosairi S |title=Sella size and contents in Sheehan's syndrome |journal=Clin. Endocrinol. (Oxf) |volume=30 |issue=6 |pages=613–8 |year=1989 |pmid=2591059 |doi= |url=}}</ref><ref name="pmid1906495">{{cite journal |vauthors=Bakiri F, Bendib SE, Maoui R, Bendib A, Benmiloud M |title=The sella turcica in Sheehan's syndrome: computerized tomographic study in 54 patients |journal=J. Endocrinol. Invest. |volume=14 |issue=3 |pages=193–6 |year=1991 |pmid=1906495 |doi=10.1007/BF03346787 |url=}}</ref> | ||
===Ultrasound=== | ===Ultrasound=== | ||
Echo findings associated with Sheehan's syndrome may include reversible dilated cardiomyopathy and pericardial effusion.<ref name="pmid1553916">{{cite journal |vauthors=Frustaci A, Perrone GA, Gentiloni N, Russo MA |title=Reversible dilated cardiomyopathy due to growth hormone deficiency |journal=Am. J. Clin. Pathol. |volume=97 |issue=4 |pages=503–11 |year=1992 |pmid=1553916 |doi= |url=}}</ref><ref name="pmid21668725">{{cite journal |vauthors=Hsieh CY, Liu BY, Yang YN, Yin WH, Young MS |title=Massive pericardial effusion with diastolic right ventricular compression secondary to hypothyroidism in a 73-year-old woman |journal=Emerg Med Australas |volume=23 |issue=3 |pages=372–5 |year=2011 |pmid=21668725 |doi=10.1111/j.1742-6723.2011.01425.x |url=}}</ref> | |||
===Other Imaging Findings=== | ===Other Imaging Findings=== | ||
| Line 65: | Line 65: | ||
==Treatment== | ==Treatment== | ||
===Medical Therapy=== | ===Medical Therapy=== | ||
Treatment involves appropriate | Treatment involves appropriate hormone replacement therapy that results in complete recovery and reversal of symptoms. | ||
===Surgery=== | ===Surgery=== | ||
| Line 71: | Line 71: | ||
===Primary Prevention=== | ===Primary Prevention=== | ||
Effective measures for the primary prevention of Sheehan's syndrome include; improved | Effective measures for the primary prevention of Sheehan's syndrome include; improved obstetrical care and peri-natal monitoring, prevention of pregnancy related complications, maternal awareness about Sheehan's syndrome and risk factors causing it and post-puerperal follow up. | ||
===Secondary Prevention=== | ===Secondary Prevention=== | ||
Effective measures for the | Effective measures for the secondary prevention include early diagnosis and treatment to prevent life threatening complications. | ||
==References== | ==References== | ||
Revision as of 15:20, 29 August 2017
|
Sheehan's syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sheehan's syndrome overview On the Web |
|
American Roentgen Ray Society Images of Sheehan's syndrome overview |
|
Risk calculators and risk factors for Sheehan's syndrome overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Iqra Qamar M.D.[2]
Overview
Historical Perspective
Sheehan's syndrome was first discovered by Leon Konrad Gliński about a century ago and it was named after Harold Sheehan (1900-1988).[1][2]
Classification
There is no established system for the classification of Sheehan's syndrome
Pathophysiology
It is thought that Sheehan's syndrome is the result of ischemic necrosis of pituitary gland due to pituitary gland enlargement during parturition precipitated by hypotension due to massive hemorrhage. Apart from pituitary gland enlargement during and before parturition, vasospasm, generalized Schwartzman phenomenon,thrombosis and compression of the hypophyseal arteries, autoimmunity, DIC and smaller size of sella are thought to play a contributing role in pathogenesis of Sheehan syndrome.[3][4][5] Occlusion and other vascular anomalies of the hypophyseal portal system can also cause complications in the exchange of hormones between the hypothalamus and the pituitary gland leading to hypopituitarism. Sheehan's syndrome results in mild to severe pituitary dysfunction resulting in partial or panhypopituitarism such as growth hormone (GH), thyroid hormone, glucocorticoid, gonadotropins and prolactin hormone deficiencies that manifests as a wide spectrum of presentation.[6] Usually, GH is the earliest one to be lost.[3]
Causes
Common causes of Sheehan's syndrome include massive hemorrhage, hypotension during pregnancy, vascular compression, and vascular occlusion (thrombosis, DIC). Less common causes include vascular insufficiency due to CABG in older patients and snake bites (Russell's viper bites).
Differentiating Sheehan's syndrome from Other Diseases
Sheehan syndrome must be differentiated from lymphocytic hypophysitis, pituitary apoplexy, hypothyroidism, Addison's disease, panhypopituitarism, empty sella syndrome, hypogonadotropic hypogonadism, Simmond's disease, hypoprolactinemia and menopause.[7][8][9]
Epidemiology and Demographics
The incidence of Sheehan's syndrome is difficult to assess.[10] It was found to be the 6th most common cause of GH deficiency with an incidence of 3.1% of cases.[11] In 2009, the prevalence of Sheehan's syndrome was estimated to be 5.1 per 100,000 women.It is less prevalent in developed countries due to better obstetrical care and maternal health awraeness.[12][13] It is still one of the most common causes of hypopituitarism in developing countries.[13]
Risk Factors
Common risk factors in the development of Sheehan's syndrome include pregnancy, severe/massive PPH, pituitary mass, pre-existing vascular diseases, autoimmunity,type 1 Diabetes, DIC, smaller and rigid sella, multiple gestations, placental abnormalities and traumatic delivery.
Screening
There is insufficient evidence to recommend routine screening for Sheehan's syndrome.
Natural History, Complications, and Prognosis
Sheehan's syndrome, if left untreated lead to hypopituitarism and empty sella syndrome. Common complications include adrenal crisis, hypotension, hypothyroidism and hypopituitarism. Prognosis is generally excellent provided early diagnosis and management resulting in complete reversal of symptoms.
Diagnosis
Diagnosis is made on clinical basis with a recent/remote history of traumatic delivery or delivery complicated by hypotension. Diagnosis is mostly clinical but detailed medical history, measurement of pituitary hormone levels in blood, pituitary hormone stimulation tests and imaging (MRI preferred on CT) studies can help in making the diagnosis.
History and Symptoms
The most common symptoms of Sheehan's sydrome include agalactorrhea and failure to resume menstruation after parturition. Common symptoms include hot flushes, decreased pubic/axillary hair, hypotension, hypoglycemia, features of hypothyroidism, hypoadrenalism and hypogonadism.
Physical Examination
Patients with syndrome usually appear fatigued, lethargic and weight gain. Physical examination is usually remarkable for bradycardia, hypotension, pallor and signs suggestive of respective hormonal deficiency.
Laboratory Findings
Laboratory findings consistent with the diagnosis of Sheehan's syndrome include hyponatremia, hypokalemia, hypocalcemia, hypomagnesemia, hypophosphatemia, anemia, pancytopenia, eosinophilia, hypoalbuminemia, low fasting plasma glucose etc.
Electrocardiogram
ECG findings associated with Sheehan's syndrome can include QT interval prolongation,Type-1 Brugada-like ECG pattern(due to adrenal crisis),findings suggestive of cardiac tamponade, dilated cardiomyopathy(multifactorial).[14][15][16][17]
X-ray
There are no x-ray findings associated with Sheehan's syndrome.
CT scan
Acute presentation shows non-hemorrhagic pituitary gland enlargement while chronic presentation shows an empty sella or decreased sellar volume.[18][19][20]
MRI
Findings on MRI suggestive of Sheehan's syndrome include decreased sellar volume, empty sella, pituitary remnant tissue or CSF fluid in sella.[18][19][20]
Ultrasound
Echo findings associated with Sheehan's syndrome may include reversible dilated cardiomyopathy and pericardial effusion.[21][22]
Other Imaging Findings
There are no other imaging findings associated with Sheehan's syndrome.
Other Diagnostic Studies
There are no additional diagnostic findings for Sheehan's syndrome.
Treatment
Medical Therapy
Treatment involves appropriate hormone replacement therapy that results in complete recovery and reversal of symptoms.
Surgery
Surgical intervention is not recommended for the management of Sheehan's syndrome.
Primary Prevention
Effective measures for the primary prevention of Sheehan's syndrome include; improved obstetrical care and peri-natal monitoring, prevention of pregnancy related complications, maternal awareness about Sheehan's syndrome and risk factors causing it and post-puerperal follow up.
Secondary Prevention
Effective measures for the secondary prevention include early diagnosis and treatment to prevent life threatening complications.
References
- ↑ Template:WhoNamedIt
- ↑ H. L. Sheehan. Post-partum necrosis of anterior pituitary. The Journal of Pathology and Bacteriology, Chichester, 1937, 45: 189-214.
- ↑ 3.0 3.1 Keleştimur F (2003). "Sheehan's syndrome". Pituitary. 6 (4): 181–8. PMID 15237929.
- ↑ Apitz, Kurt (September 1, 1935). "A Study of the Generalized Shwartzman Phenomenon". The Journal of Immunology. 29 (3): 255–266.
- ↑ McKay, Donald G.; Merrill, Samuel J.; Weiner, Albert E.; Hertig, Arthur T.; Reid, Duncan E. (1953). "The pathologic anatomy of eclampsia, bilateral renal cortical necrosis, pituitary necrosis, and other acute fatal complications of pregnancy, and its possible relationship to the generalized Shwartzman phenomenon". American Journal of Obstetrics and Gynecology. 66 (3): 507–539. doi:10.1016/0002-9378(53)90068-4. ISSN 0002-9378.
- ↑ Vance ML (1994). "Hypopituitarism". N. Engl. J. Med. 330 (23): 1651–62. doi:10.1056/NEJM199406093302306. PMID 8043090.
- ↑ Rolih CA, Ober KP (1993). "Pituitary apoplexy". Endocrinol. Metab. Clin. North Am. 22 (2): 291–302. PMID 8325288.
- ↑ Vidal E, Cevallos R, Vidal J, Ravon R, Moreau JJ, Rogues AM, Loustaud V, Liozon F (1992). "Twelve cases of pituitary apoplexy". Arch. Intern. Med. 152 (9): 1893–9. PMID 1520058.
- ↑ Lazaro CM, Guo WY, Sami M, Hindmarsh T, Ericson K, Hulting AL, Wersäll J (1994). "Haemorrhagic pituitary tumours". Neuroradiology. 36 (2): 111–4. PMID 8183446.
- ↑ Asaoka K (1977). "[A study on the incidence of post-partum hypopituitarism, (Sheehan's syndrome)]". Nihon Naibunpi Gakkai Zasshi (in Japanese). 53 (7): 895–909. PMID 303183.
- ↑ Abs R, Bengtsson BA, Hernberg-Stâhl E, Monson JP, Tauber JP, Wilton P, Wüster C (1999). "GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety". Clin. Endocrinol. (Oxf). 50 (6): 703–13. PMID 10468941.
- ↑ Feinberg EC, Molitch ME, Endres LK, Peaceman AM (2005). "The incidence of Sheehan's syndrome after obstetric hemorrhage". Fertil. Steril. 84 (4): 975–9. doi:10.1016/j.fertnstert.2005.04.034. PMID 16213852.
- ↑ 13.0 13.1 Krysiak R, Okopień B (2015). "[Sheehan's syndrome--a forgotten disease with 100 years' history]". Prz. Lek. (in Polish). 72 (6): 313–20. PMID 26817341.
- ↑ Komuro J, Kaneko M, Ueda K, Nitta S, Kasao M, Shirai T (2016). "Adrenal insufficiency causes life-threatening arrhythmia with prolongation of QT interval". Heart Vessels. 31 (6): 1003–5. doi:10.1007/s00380-015-0660-6. PMC 4893060. PMID 25771803.
- ↑ Anselm DD, Baranchuk A (2015). "Confirmed Brugada phenocopy in the setting of hypopituitarism". Herz. 40 (4): 639–40. doi:10.1007/s00059-014-4075-4. PMID 24718975.
- ↑ Martin-Grace J, Ahmed M, Mulvihill N, Feeney ER, Crowley RK (2017). "Getting to the heart of hypopituitarism". Clin Med (Lond). 17 (2): 140–142. doi:10.7861/clinmedicine.17-2-140. PMID 28365624.
- ↑ Doshi S, Roy A, Ramamoorthy A, Kothari SS, Bahl VK (2013). "Dilated cardiomyopathy: a ghost from the past". Circ Heart Fail. 6 (2): e19–21. doi:10.1161/CIRCHEARTFAILURE.112.000062. PMID 23513050.
- ↑ 18.0 18.1 Barkan AL (1989). "Pituitary atrophy in patients with Sheehan's syndrome". Am. J. Med. Sci. 298 (1): 38–40. PMID 2750772.
- ↑ 19.0 19.1 Sherif IH, Vanderley CM, Beshyah S, Bosairi S (1989). "Sella size and contents in Sheehan's syndrome". Clin. Endocrinol. (Oxf). 30 (6): 613–8. PMID 2591059.
- ↑ 20.0 20.1 Bakiri F, Bendib SE, Maoui R, Bendib A, Benmiloud M (1991). "The sella turcica in Sheehan's syndrome: computerized tomographic study in 54 patients". J. Endocrinol. Invest. 14 (3): 193–6. doi:10.1007/BF03346787. PMID 1906495.
- ↑ Frustaci A, Perrone GA, Gentiloni N, Russo MA (1992). "Reversible dilated cardiomyopathy due to growth hormone deficiency". Am. J. Clin. Pathol. 97 (4): 503–11. PMID 1553916.
- ↑ Hsieh CY, Liu BY, Yang YN, Yin WH, Young MS (2011). "Massive pericardial effusion with diastolic right ventricular compression secondary to hypothyroidism in a 73-year-old woman". Emerg Med Australas. 23 (3): 372–5. doi:10.1111/j.1742-6723.2011.01425.x. PMID 21668725.